Shayne & Jacobs LLC’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
9,060
-50
-0.5% -$13.1K 0.75% 30
2026
Q1
$2.43M Hold
9,110
0.75% 25
2025
Q4
$2.29M Hold
9,110
0.69% 27
2025
Q3
$2.62M Hold
9,110
0.81% 21
2025
Q2
$2.39M Hold
9,110
0.79% 22
2025
Q1
$2.12M Sell
9,110
-95
-1% -$23.1K 0.52% 24
2024
Q4
$2.11M Buy
9,205
+40
+0.4% +$9.18K 0.55% 25
2024
Q3
$2.05M Buy
9,165
+130
+1% +$28.6K 0.51% 28
2024
Q2
$1.84M Buy
9,035
+740
+9% +$151K 0.51% 28
2024
Q1
$1.81M Sell
8,295
-70
-0.8% -$15.4K 0.49% 30
2023
Q4
$1.9M Hold
8,365
0.59% 29
2023
Q3
$1.68M Buy
+8,365
New +$1.76M 0.56% 28

Other funds holding LH

Shayne & Jacobs LLC's LH Position: Q2 2026 in Review

Shayne & Jacobs LLC reduced its Labcorp (LH) stake by 0.55% in Q2 2026, selling an estimated $13.1K and leaving 9,060 shares worth $2.54M. The position accounts for 0.75% of the portfolio, ranked #30.

Shayne & Jacobs LLC first reported a position in LH in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.62M in Q3 2025. 401 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Shayne & Jacobs LLC held 9,060 shares of Labcorp worth $2.54M as of Q2 2026.
  • Shayne & Jacobs LLC sold 50 Labcorp shares in Q2 2026, an estimated $13.1K.
  • Labcorp made up 0.75% of Shayne & Jacobs LLC's portfolio in Q2 2026, its #30 holding.
  • Shayne & Jacobs LLC first reported a position in Labcorp in Q3 2023 and has held it in 12 quarters since.
  • Shayne & Jacobs LLC's Labcorp position peaked at $2.62M in Q3 2025.
  • 401 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q2 2026, filed 7 Jul 2026.